YOUNG RESEARCH SUBJECTS, OLD PROBLEMS Prof dr I.D. de Beaufort - - PowerPoint PPT Presentation

young research subjects old problems
SMART_READER_LITE
LIVE PREVIEW

YOUNG RESEARCH SUBJECTS, OLD PROBLEMS Prof dr I.D. de Beaufort - - PowerPoint PPT Presentation

YOUNG RESEARCH SUBJECTS, OLD PROBLEMS Prof dr I.D. de Beaufort Department of Medical Ethics and Philospohy To experiment on children in ways that are not related to them as patients is already a sanitized form of barbarism which pays


slide-1
SLIDE 1

YOUNG RESEARCH SUBJECTS, OLD PROBLEMS

Prof dr I.D. de Beaufort Department of Medical Ethics and Philospohy

slide-2
SLIDE 2
slide-3
SLIDE 3
  • “To experiment on children in ways that are

not related to them as patients is already a sanitized form of barbarism which pays no attention to the faithfulness-claims which a child, simply by being a normal or a sick

  • r a dying child, places upon us and

medical care.”

slide-4
SLIDE 4
slide-5
SLIDE 5
slide-6
SLIDE 6
slide-7
SLIDE 7
slide-8
SLIDE 8

Balancing between non-maleficence, dignity, beneficence and solidarity

slide-9
SLIDE 9
slide-10
SLIDE 10

To use (off-label) treatments on children that have not been subject of research is, prima facie, unethical.

slide-11
SLIDE 11
slide-12
SLIDE 12
slide-13
SLIDE 13
slide-14
SLIDE 14
slide-15
SLIDE 15
slide-16
SLIDE 16

NON-THERAPEUTIC PROCEDURES OR TRIALS

slide-17
SLIDE 17

MINIMAL RISK AND MINIMAL BURDEN

slide-18
SLIDE 18
  • What is minimal risk and minimal inconvenience/

burden

  • Should exceptions be allowed and when?
  • No exceptions should be allowed as a matter of

principle

  • Too difficult to decide when and which exceptions

should be allowed

  • A slippery slope
slide-19
SLIDE 19

A minor increase over minimal risk

slide-20
SLIDE 20

Stretching the notion of benefit and therapeutic

slide-21
SLIDE 21

It is therapeutic in a moral sense.

slide-22
SLIDE 22
  • It is taking a rain check on the future
  • It may justify too much!
  • Children need not be ‘mini Samaritans’
slide-23
SLIDE 23
slide-24
SLIDE 24
slide-25
SLIDE 25
slide-26
SLIDE 26
  • We recommend Europe to adopt a policy

that is more closely related to the two factors that determine when exceptions to the minimal risk and burden can be justified: the assent of the research subjects and the value of the study.

slide-27
SLIDE 27

VIR Very Important Research

slide-28
SLIDE 28

For a study to be exceptionally valuable, the desired data much be truly indispensable for improving medical care for children.

slide-29
SLIDE 29
slide-30
SLIDE 30
slide-31
SLIDE 31

Strict scientific standards

slide-32
SLIDE 32

The assent of the child

slide-33
SLIDE 33
slide-34
SLIDE 34

A ‘NATIONAL’ APPROACH

slide-35
SLIDE 35

ATTENTION FOR ETHICAL REVIEW TOURISM

slide-36
SLIDE 36

CHILDRENS VIEWS AND EXPERIENCES

slide-37
SLIDE 37

Focus groups with pediatricians, parents and children may be helpful.

slide-38
SLIDE 38

AWARENESS OF OTHER GROUPS OF PATIENTS